drug: hydromorphone
- Clinical class: narcotic analgesic
- Chemical class: opioid, hydrogenated ketone of morphine
- CSA schedule: II
- DEA number: 9150
- Route of administration: oral, injected, rectal
- Associated with (substance-related): disorders
- Availability: prescription, street
- MEDLINEplus® Drug Information: oral, rectal
- MEDLINEplus® Drug Information: injected
U.S. Preparations:
- Dilaudid® (Abbott Laboratories) FDA approved indications: analgesia
- Hydromorphone HCl Tablets, USP (Endo Pharmaceuticals Inc.) FDA approved indications: analgesia
- Hydrostat® IR (Richwood) FDA approved indications: analgesia
- Palladone™ (Purdue) FDA approved
indications: management of persistent, moderate to severe pain in
patients requiring continuous, around-the-clock analgesia with a high potency
opioid for an extended period of time generally weeks to months or longer.
Palladone™ Capsules should only be used in patients who are already receiving
opioid therapy, have demonstrated opioid tolerance, and who require a minimum
total daily dose of opiate medication equivalent to 12 mg of oral
hydromorphone 9.24.2004
Withdrawn at the request of FDA 7.13.2005
U.S. Prescribing information
Street names:
- dillys, drug store heroin
| Books and Other Media: Follow the hypertext link to purchase items online. |
|
